Vitor Silva Pereira1, Angélica Romano2, Gregers Wegener3,4, Sâmia R L Joca5,6. 1. Department of Pharmacology, School of Medicine, Campus USP-Ribeirão Preto, Ribeirão Preto, SP, 14049-900, Brazil. 2. Department of Physics and Chemistry, School of Pharmaceutical Sciences of Ribeirão Preto (FCFRP), University of São Paulo (USP), Cafe Av, s/n, Ribeirão Preto, SP, 14040-903, Brazil. 3. Translational Neuropsychiatry Unit, Department of Clinical Medicine, Aarhus University, 8240, Risskov, Denmark. 4. Centre of Excellence for Pharmaceutical Sciences, North West University, Potchefstroom, 2520, South Africa. 5. Department of Physics and Chemistry, School of Pharmaceutical Sciences of Ribeirão Preto (FCFRP), University of São Paulo (USP), Cafe Av, s/n, Ribeirão Preto, SP, 14040-903, Brazil. samia@usp.br. 6. Center for Interdisciplinary Research on Applied Neurosciences (NAPNA), University of São Paulo, São Paulo, Brazil. samia@usp.br.
Abstract
RATIONALE: Systemic treatment with NMDA receptor (NMDAR) antagonists, inhibitors of neuronal nitric oxide synthase (nNOS) or of soluble guanylyl cyclase (sGC), induce antidepressant-like effects in rats. Increased levels of glutamate and nitric oxide (NO) in the medial prefrontal cortex (MPFC) of stressed animals have been described in the literature. However, the role of the NMDAR-nNOS-sGC pathway of the MPFC in the mediation of forced swim-induced behaviors remains unclear. OBJECTIVE: The aim of this work was to test the hypothesis that the inhibition of the NMDAR-nNOS-sGC pathway in the ventral MPFC (infralimbic (IL) or prelimbic (PL)) would elicit antidepressant-like effects in the forced swim test (FST). METHODS: Rats implanted with cannulae aimed at the PL or the IL were exposed to the FST and injected with LY235959 (NMDAR antagonist), NPA (nNOS inhibitor), ODQ (sGC inhibitor), or carboxy-PTIO (NO scavenger). Additional groups received the AMPA antagonist, NBQX, before the effective doses of LY235959 or NPA. RESULTS: LY235959 administration into PL or IL before the FS pretest produced no effects. Administration of LY235959 (3 and 10 nmol/0.2 μL) after pretest was effective only when administered into the PL. However, the administration of NPA (0.01 nmol/0.2 μL), c-PTIO (1.0 nmol/0.2 μL), and ODQ (1.0 nmol/0.2 μL) into the PL or IL before the FST produced antidepressant-like effects. NBQX blocked the antidepressant-like effect of LY235959 but not of NPA. CONCLUSION: Blocking NMDAR or NO signaling in the vMPFC, either in the IL or the PL, induces antidepressant-like effects in the rat FST. These effects seemingly occur through independent mechanisms, since NBQX blocked the former effect but not the latter.
RATIONALE: Systemic treatment with NMDA receptor (NMDAR) antagonists, inhibitors of neuronal nitric oxide synthase (nNOS) or of soluble guanylyl cyclase (sGC), induce antidepressant-like effects in rats. Increased levels of glutamate and nitric oxide (NO) in the medial prefrontal cortex (MPFC) of stressed animals have been described in the literature. However, the role of the NMDAR-nNOS-sGC pathway of the MPFC in the mediation of forced swim-induced behaviors remains unclear. OBJECTIVE: The aim of this work was to test the hypothesis that the inhibition of the NMDAR-nNOS-sGC pathway in the ventral MPFC (infralimbic (IL) or prelimbic (PL)) would elicit antidepressant-like effects in the forced swim test (FST). METHODS:Rats implanted with cannulae aimed at the PL or the IL were exposed to the FST and injected with LY235959 (NMDAR antagonist), NPA (nNOS inhibitor), ODQ (sGC inhibitor), or carboxy-PTIO (NO scavenger). Additional groups received the AMPA antagonist, NBQX, before the effective doses of LY235959 or NPA. RESULTS:LY235959 administration into PL or IL before the FS pretest produced no effects. Administration of LY235959 (3 and 10 nmol/0.2 μL) after pretest was effective only when administered into the PL. However, the administration of NPA (0.01 nmol/0.2 μL), c-PTIO (1.0 nmol/0.2 μL), and ODQ (1.0 nmol/0.2 μL) into the PL or IL before the FST produced antidepressant-like effects. NBQX blocked the antidepressant-like effect of LY235959 but not of NPA. CONCLUSION: Blocking NMDAR or NO signaling in the vMPFC, either in the IL or the PL, induces antidepressant-like effects in the rat FST. These effects seemingly occur through independent mechanisms, since NBQX blocked the former effect but not the latter.
Authors: Vitor S Pereira; Plinio C Casarotto; Vinícius A Hiroaki-Sato; Ariandra G Sartim; Francisco S Guimarães; Sâmia R L Joca Journal: Eur Neuropsychopharmacol Date: 2013-02-20 Impact factor: 4.600
Authors: Sungho Maeng; Carlos A Zarate; Jing Du; Robert J Schloesser; Joseph McCammon; Guang Chen; Husseini K Manji Journal: Biol Psychiatry Date: 2007-07-23 Impact factor: 13.382
Authors: Lucas Lm Tonetto; Ana L Terzian; Elaine A Del Bel; Francisco S Guimarães; Leonardo Bm Resstel Journal: Behav Brain Funct Date: 2009-09-23 Impact factor: 3.759
Authors: Arthur A Coelho; Carla Vila-Verde; Ariandra G Sartim; Daniela L Uliana; Laura A Braga; Francisco S Guimarães; Sabrina F Lisboa Journal: Front Psychiatry Date: 2022-07-14 Impact factor: 5.435
Authors: Nicolas Panayotis; Philip A Freund; Letizia Marvaldi; Tali Shalit; Alexander Brandis; Tevie Mehlman; Michael M Tsoory; Mike Fainzilber Journal: Cell Rep Med Date: 2021-05-18